Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Insulin Aspart Added to Insulin Degludec in T2D (BEGIN: VICTOZA ADD-ON)
NCT01388361Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2011
- Primary completion
- Jul 2012
- Modality
- Peptides
- Countries
- 12
01
Overview
A Phase 3 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Sep 2011; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01388361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01388361.